Serum soluble CD23 levels in giant cell arteritis' - Inserm - Institut national de la santé et de la recherche médicale
Article Dans Une Revue Immunology Letters Année : 1996

Serum soluble CD23 levels in giant cell arteritis'

Résumé

Lymphocytes and monocytes express various levels of membrane-bound CD23, the low affinity receptor for IgE (FceRII), and in some cases release it as a soluble form. Soluble CD23 (sCD23) has been implicated in the regulation of many immunological functions of T and B lymphocytes, macrophages and myeloid cells in humans. To study serum sCD23 levels in inflammatory conditions, we selected a systemic disease sensitive to corticotherapy, the giant cell arteritis, which is characterized by an inflammation of the temporal artery. Serum sCD23 levels, as measured by a radioimmunoassay, were increased in these patients, and returned to normal values within the 24 h following initiation of corticotherapy. The data suggest that the increase in sCD23 levels in giant cell arteritis results from an overproduction.

Domaines

Immunologie
Fichier principal
Vignette du fichier
serum CD23.pdf (350.18 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

inserm-03549093 , version 1 (31-01-2022)

Identifiants

Citer

Pascal Roblot, Franck Morel, Eric Lelièvre, Marie-Hélène Biais-Sauvètre, Donat de Groote, et al.. Serum soluble CD23 levels in giant cell arteritis'. Immunology Letters, 1996, 53 (1), pp.41. ⟨10.1016/0165-2478(96)02612-0⟩. ⟨inserm-03549093⟩

Collections

INSERM CNRS
9 Consultations
52 Téléchargements

Altmetric

Partager

More